DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Smolen JS, Genovese MC, Takeuchi T. et al.
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment.
J Rheumatol 2019;
46: 7-18
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.